Cow's milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age.
BACKGROUND
Cow's milk allergy (CMA) has been found to be associated with an increased incidence of asthma at school age. However, prospective population-based studies of CMA and the development of airway inflammation and bronchial hyperresponsivess (BHR) are lacking.


OBJECTIVE
The aims of this study was to evaluate CMA as a risk factor for BHR and airway inflammation presented later in childhood.


METHODS
We followed prospectively 118 children with CMA and invited them to a clinical visit at a mean age of 8.6 years including the measurement of exhaled nitric oxide (FE(NO) ) and bronchial challenge with histamine. Ninety-four patients and 80 control subjects from the same cohort participated.


RESULTS
At school age, children with a history of CMA had higher FE(NO) levels (P=0.0009) and more pronounced responsiveness to histamine (P=0.027) than their controls. Stratified analysis showed a significant difference only in IgE-positive CMA. Multinomial logistic regression analysis showed that IgE-positive CMA [odds ratio (OR) 3.51; 95% confidence intervals (CI) 1.56-7.90; P=0.002] and a history of wheeze during the first year of life (OR 2.81; 95% CI 1.16-6.84; P=0.023) were independent explanatory factors for increased FE(NO) , and IgE-positive CMA (OR 3.37; 95% CI 1.03-10.97; P=0.044) and parental smoking (OR 3.41; 95% CI 1.14-10.22; P=0.028) for increased BHR, whereas for IgE-negative CMA, no associations with FE(NO) or BHR were found. In the CMA group, those exposed to CM very early at the maternity hospital, had less BHR (P=0.002).


CONCLUSIONS
Compared with their controls, children with a history of IgE-positive CMA show signs of airway inflammation, expressed as higher FE(NO) , and more pronounced bronchial responsiveness to histamine at school age. In contrast to IgE-negative CMA, IgE-positive CMA is a significant predictor of increased FE(NO) and BHR at school age. Very early exposure to CM was associated with less BHR.
Malmberg
L P
LP
Department of Allergy, Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland. pekka.malmberg@hus.fi
Saarinen
K M
KM
Pelkonen
A S
AS
Savilahti
E
E
Mäkelä
M J
MJ
D000818:Animals; D016535:Bronchial Hyperreactivity / Q000150:complications* / Q000276:immunology; D001985:Bronchial Provocation Tests; D002417:Cattle; D002648:Child; D045853:Exhalation; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008892:Milk / Q000276:immunology; D016269:Milk Hypersensitivity / Q000150:complications* / Q000276:immunology; D009569:Nitric Oxide / Q000032:analysis; D011014:Pneumonia / Q000150:complications* / Q000276:immunology; D012129:Respiratory Function Tests; D012307:Risk Factors; D012882:Skin Tests
D009569:Nitric Oxide; D007073:Immunoglobulin E